Food and Drug Administration broad Agency Announcement or the Advanced Research and Development of Regulatory Science

The Food and Drug Administration has issued a Broad Agency Announcement (BAA) seeking advanced research and development proposals aimed at enhancing regulatory science and fostering innovation. This initiative intends to support the FDA’s core mission of protecting and promoting public health by advancing scientific knowledge through research activities. The BAA is a renewal of a previous announcement from fiscal year 2019 and remains open indefinitely, with annual renewals, allowing ongoing opportunities for submissions in relevant scientific fields. The solicitation, identified under number FDABAA-20-00123 and classified under NAICS code 5417, invites proposals without specific set-aside restrictions or designated organizational types. While precise project locations are not defined, the FDA provides points of contact for interested parties, including a Lead Contract Specialist and a Contract Specialist, who can offer guidance and information. This open-ended BAA reflects the FDA’s commitment to continuous innovation in regulatory science and encourages researchers to contribute to advancing the agency's regulatory framework and public health objectives.